Global Anti-Infective Ophthalmic Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Anti-Infective Ophthalmic market size is predicted to grow from US$ 1533 million in 2025 to US$ 1877 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infective Ophthalmic Industry Forecast” looks at past sales and reviews total world Anti-Infective Ophthalmic sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infective Ophthalmic sales for 2025 through 2031. With Anti-Infective Ophthalmic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Ophthalmic industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Ophthalmic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Ophthalmic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infective Ophthalmic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Ophthalmic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Ophthalmic.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Ophthalmic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Infective Ophthalmic market?
What factors are driving Anti-Infective Ophthalmic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Ophthalmic market opportunities vary by end market size?
How does Anti-Infective Ophthalmic break out by Type, by Application?
The global Anti-Infective Ophthalmic market size is predicted to grow from US$ 1533 million in 2025 to US$ 1877 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infective Ophthalmic Industry Forecast” looks at past sales and reviews total world Anti-Infective Ophthalmic sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infective Ophthalmic sales for 2025 through 2031. With Anti-Infective Ophthalmic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Ophthalmic industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infective Ophthalmic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Ophthalmic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infective Ophthalmic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Ophthalmic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Ophthalmic.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Ophthalmic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Eyedrops
- Gels
- Ointments
- Other
- Hospital
- Retail Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alcon
- AbbVie
- Bausch Health
- Santen Pharmaceutical
- Lupin Pharmaceuticals
- Apotex
- Akorn
- Johnson & Johnson
- Thea pharmaceuticals
- URSAPHARM
- SIMILASAN
- Jianfeng Group
What is the 10-year outlook for the global Anti-Infective Ophthalmic market?
What factors are driving Anti-Infective Ophthalmic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infective Ophthalmic market opportunities vary by end market size?
How does Anti-Infective Ophthalmic break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Ophthalmic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infective Ophthalmic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infective Ophthalmic by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infective Ophthalmic Segment by Type
2.2.1 Eyedrops
2.2.2 Gels
2.2.3 Ointments
2.2.4 Other
2.3 Anti-Infective Ophthalmic Sales by Type
2.3.1 Global Anti-Infective Ophthalmic Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infective Ophthalmic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infective Ophthalmic Sale Price by Type (2020-2025)
2.4 Anti-Infective Ophthalmic Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Anti-Infective Ophthalmic Sales by Application
2.5.1 Global Anti-Infective Ophthalmic Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infective Ophthalmic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infective Ophthalmic Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infective Ophthalmic Breakdown Data by Company
3.1.1 Global Anti-Infective Ophthalmic Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infective Ophthalmic Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infective Ophthalmic Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infective Ophthalmic Revenue by Company (2020-2025)
3.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infective Ophthalmic Sale Price by Company
3.4 Key Manufacturers Anti-Infective Ophthalmic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Ophthalmic Product Location Distribution
3.4.2 Players Anti-Infective Ophthalmic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE OPHTHALMIC BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Ophthalmic Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infective Ophthalmic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infective Ophthalmic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infective Ophthalmic Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infective Ophthalmic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infective Ophthalmic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infective Ophthalmic Sales Growth
4.4 APAC Anti-Infective Ophthalmic Sales Growth
4.5 Europe Anti-Infective Ophthalmic Sales Growth
4.6 Middle East & Africa Anti-Infective Ophthalmic Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Ophthalmic Sales by Country
5.1.1 Americas Anti-Infective Ophthalmic Sales by Country (2020-2025)
5.1.2 Americas Anti-Infective Ophthalmic Revenue by Country (2020-2025)
5.2 Americas Anti-Infective Ophthalmic Sales by Type (2020-2025)
5.3 Americas Anti-Infective Ophthalmic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Ophthalmic Sales by Region
6.1.1 APAC Anti-Infective Ophthalmic Sales by Region (2020-2025)
6.1.2 APAC Anti-Infective Ophthalmic Revenue by Region (2020-2025)
6.2 APAC Anti-Infective Ophthalmic Sales by Type (2020-2025)
6.3 APAC Anti-Infective Ophthalmic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Ophthalmic by Country
7.1.1 Europe Anti-Infective Ophthalmic Sales by Country (2020-2025)
7.1.2 Europe Anti-Infective Ophthalmic Revenue by Country (2020-2025)
7.2 Europe Anti-Infective Ophthalmic Sales by Type (2020-2025)
7.3 Europe Anti-Infective Ophthalmic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Ophthalmic by Country
8.1.1 Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infective Ophthalmic Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infective Ophthalmic Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infective Ophthalmic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Ophthalmic
10.3 Manufacturing Process Analysis of Anti-Infective Ophthalmic
10.4 Industry Chain Structure of Anti-Infective Ophthalmic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Ophthalmic Distributors
11.3 Anti-Infective Ophthalmic Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE OPHTHALMIC BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Ophthalmic Market Size Forecast by Region
12.1.1 Global Anti-Infective Ophthalmic Forecast by Region (2026-2031)
12.1.2 Global Anti-Infective Ophthalmic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infective Ophthalmic Forecast by Type (2026-2031)
12.7 Global Anti-Infective Ophthalmic Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alcon
13.1.1 Alcon Company Information
13.1.2 Alcon Anti-Infective Ophthalmic Product Portfolios and Specifications
13.1.3 Alcon Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alcon Main Business Overview
13.1.5 Alcon Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Anti-Infective Ophthalmic Product Portfolios and Specifications
13.2.3 AbbVie Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Anti-Infective Ophthalmic Product Portfolios and Specifications
13.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Santen Pharmaceutical
13.4.1 Santen Pharmaceutical Company Information
13.4.2 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolios and Specifications
13.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Santen Pharmaceutical Main Business Overview
13.4.5 Santen Pharmaceutical Latest Developments
13.5 Lupin Pharmaceuticals
13.5.1 Lupin Pharmaceuticals Company Information
13.5.2 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
13.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lupin Pharmaceuticals Main Business Overview
13.5.5 Lupin Pharmaceuticals Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Anti-Infective Ophthalmic Product Portfolios and Specifications
13.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Akorn
13.7.1 Akorn Company Information
13.7.2 Akorn Anti-Infective Ophthalmic Product Portfolios and Specifications
13.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Akorn Main Business Overview
13.7.5 Akorn Latest Developments
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Information
13.8.2 Johnson & Johnson Anti-Infective Ophthalmic Product Portfolios and Specifications
13.8.3 Johnson & Johnson Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Johnson & Johnson Main Business Overview
13.8.5 Johnson & Johnson Latest Developments
13.9 Thea pharmaceuticals
13.9.1 Thea pharmaceuticals Company Information
13.9.2 Thea pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
13.9.3 Thea pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Thea pharmaceuticals Main Business Overview
13.9.5 Thea pharmaceuticals Latest Developments
13.10 URSAPHARM
13.10.1 URSAPHARM Company Information
13.10.2 URSAPHARM Anti-Infective Ophthalmic Product Portfolios and Specifications
13.10.3 URSAPHARM Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 URSAPHARM Main Business Overview
13.10.5 URSAPHARM Latest Developments
13.11 SIMILASAN
13.11.1 SIMILASAN Company Information
13.11.2 SIMILASAN Anti-Infective Ophthalmic Product Portfolios and Specifications
13.11.3 SIMILASAN Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SIMILASAN Main Business Overview
13.11.5 SIMILASAN Latest Developments
13.12 Jianfeng Group
13.12.1 Jianfeng Group Company Information
13.12.2 Jianfeng Group Anti-Infective Ophthalmic Product Portfolios and Specifications
13.12.3 Jianfeng Group Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jianfeng Group Main Business Overview
13.12.5 Jianfeng Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-Infective Ophthalmic Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infective Ophthalmic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Eyedrops
Table 4. Major Players of Gels
Table 5. Major Players of Ointments
Table 6. Major Players of Other
Table 7. Global Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 8. Global Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Table 9. Global Anti-Infective Ophthalmic Revenue byType (2020-2025) & ($ million)
Table 10. Global Anti-Infective Ophthalmic Revenue Market Share byType (2020-2025)
Table 11. Global Anti-Infective Ophthalmic Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Anti-Infective Ophthalmic Sale by Application (2020-2025) & (K Units)
Table 13. Global Anti-Infective Ophthalmic Sale Market Share by Application (2020-2025)
Table 14. Global Anti-Infective Ophthalmic Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-Infective Ophthalmic Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-Infective Ophthalmic Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Anti-Infective Ophthalmic Sales by Company (2020-2025) & (K Units)
Table 18. Global Anti-Infective Ophthalmic Sales Market Share by Company (2020-2025)
Table 19. Global Anti-Infective Ophthalmic Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-Infective Ophthalmic Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-Infective Ophthalmic Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Anti-Infective Ophthalmic Producing Area Distribution and Sales Area
Table 23. Players Anti-Infective Ophthalmic Products Offered
Table 24. Anti-Infective Ophthalmic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-Infective Ophthalmic Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Anti-Infective Ophthalmic Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-Infective Ophthalmic Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-Infective Ophthalmic Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-Infective Ophthalmic Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Anti-Infective Ophthalmic Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-Infective Ophthalmic Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-Infective Ophthalmic Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 36. Americas Anti-Infective Ophthalmic Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-Infective Ophthalmic Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 39. Americas Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 40. APAC Anti-Infective Ophthalmic Sales by Region (2020-2025) & (K Units)
Table 41. APAC Anti-Infective Ophthalmic Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-Infective Ophthalmic Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 44. APAC Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 45. Europe Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 46. Europe Anti-Infective Ophthalmic Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 48. Europe Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-Infective Ophthalmic
Table 54. Key Market Challenges & Risks of Anti-Infective Ophthalmic
Table 55. Key IndustryTrends of Anti-Infective Ophthalmic
Table 56. Anti-Infective Ophthalmic Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-Infective Ophthalmic Distributors List
Table 59. Anti-Infective Ophthalmic Customer List
Table 60. Global Anti-Infective Ophthalmic SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Anti-Infective Ophthalmic RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Anti-Infective Ophthalmic Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-Infective Ophthalmic SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Anti-Infective Ophthalmic Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Anti-Infective Ophthalmic RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Anti-Infective Ophthalmic RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-Infective Ophthalmic SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Anti-Infective Ophthalmic RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Anti-Infective Ophthalmic SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Anti-Infective Ophthalmic RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Alcon Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 75. Alcon Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 76. Alcon Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Alcon Main Business
Table 78. Alcon Latest Developments
Table 79. AbbVie Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 81. AbbVie Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. Bausch Health Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 85. Bausch Health Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 86. Bausch Health Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bausch Health Main Business
Table 88. Bausch Health Latest Developments
Table 89. Santen Pharmaceutical Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 90. Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 91. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Santen Pharmaceutical Main Business
Table 93. Santen Pharmaceutical Latest Developments
Table 94. Lupin Pharmaceuticals Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 96. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Lupin Pharmaceuticals Main Business
Table 98. Lupin Pharmaceuticals Latest Developments
Table 99. Apotex Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 100. Apotex Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 101. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Apotex Main Business
Table 103. Apotex Latest Developments
Table 104. Akorn Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 105. Akorn Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 106. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Akorn Main Business
Table 108. Akorn Latest Developments
Table 109. Johnson & Johnson Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 111. Johnson & Johnson Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Johnson & Johnson Main Business
Table 113. Johnson & Johnson Latest Developments
Table 114.Thea pharmaceuticals Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 115.Thea pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 116.Thea pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117.Thea pharmaceuticals Main Business
Table 118.Thea pharmaceuticals Latest Developments
Table 119. URSAPHARM Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 120. URSAPHARM Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 121. URSAPHARM Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. URSAPHARM Main Business
Table 123. URSAPHARM Latest Developments
Table 124. SIMILASAN Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 125. SIMILASAN Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 126. SIMILASAN Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. SIMILASAN Main Business
Table 128. SIMILASAN Latest Developments
Table 129. Jianfeng Group Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 130. Jianfeng Group Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 131. Jianfeng Group Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Jianfeng Group Main Business
Table 133. Jianfeng Group Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-Infective Ophthalmic
Figure 2. Anti-Infective Ophthalmic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Ophthalmic Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infective Ophthalmic Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infective Ophthalmic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infective Ophthalmic Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infective Ophthalmic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Eyedrops
Figure 12. Product Picture of Gels
Figure 13. Product Picture of Ointments
Figure 14. Product Picture of Other
Figure 15. Global Anti-Infective Ophthalmic Sales Market Share byType in 2025
Figure 16. Global Anti-Infective Ophthalmic Revenue Market Share byType (2020-2025)
Figure 17. Anti-Infective Ophthalmic Consumed in Hospital
Figure 18. Global Anti-Infective Ophthalmic Market: Hospital (2020-2025) & (K Units)
Figure 19. Anti-Infective Ophthalmic Consumed in Retail Pharmacy
Figure 20. Global Anti-Infective Ophthalmic Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Anti-Infective Ophthalmic Consumed in Others
Figure 22. Global Anti-Infective Ophthalmic Market: Others (2020-2025) & (K Units)
Figure 23. Global Anti-Infective Ophthalmic Sale Market Share by Application (2024)
Figure 24. Global Anti-Infective Ophthalmic Revenue Market Share by Application in 2025
Figure 25. Anti-Infective Ophthalmic Sales by Company in 2025 (K Units)
Figure 26. Global Anti-Infective Ophthalmic Sales Market Share by Company in 2025
Figure 27. Anti-Infective Ophthalmic Revenue by Company in 2025 ($ millions)
Figure 28. Global Anti-Infective Ophthalmic Revenue Market Share by Company in 2025
Figure 29. Global Anti-Infective Ophthalmic Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Anti-Infective Ophthalmic Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 32. Americas Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 33. APAC Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 34. APAC Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 35. Europe Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 36. Europe Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 39. Americas Anti-Infective Ophthalmic Sales Market Share by Country in 2025
Figure 40. Americas Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Figure 41. Americas Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 42. Americas Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 43. United States Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Anti-Infective Ophthalmic Sales Market Share by Region in 2025
Figure 48. APAC Anti-Infective Ophthalmic Revenue Market Share by Region (2020-2025)
Figure 49. APAC Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 50. APAC Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 51. China Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 55. India Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Anti-Infective Ophthalmic Sales Market Share by Country in 2025
Figure 59. Europe Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Figure 60. Europe Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 61. Europe Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 62. Germany Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 63.France Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 70. Egypt Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Anti-Infective Ophthalmic in 2025
Figure 76. Manufacturing Process Analysis of Anti-Infective Ophthalmic
Figure 77. Industry Chain Structure of Anti-Infective Ophthalmic
Figure 78. Channels of Distribution
Figure 79. Global Anti-Infective Ophthalmic Sales MarketForecast by Region (2026-2031)
Figure 80. Global Anti-Infective Ophthalmic Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Anti-Infective Ophthalmic Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Anti-Infective Ophthalmic Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Anti-Infective Ophthalmic Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Anti-Infective Ophthalmic Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infective Ophthalmic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infective Ophthalmic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infective Ophthalmic by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infective Ophthalmic Segment by Type
2.2.1 Eyedrops
2.2.2 Gels
2.2.3 Ointments
2.2.4 Other
2.3 Anti-Infective Ophthalmic Sales by Type
2.3.1 Global Anti-Infective Ophthalmic Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infective Ophthalmic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infective Ophthalmic Sale Price by Type (2020-2025)
2.4 Anti-Infective Ophthalmic Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Anti-Infective Ophthalmic Sales by Application
2.5.1 Global Anti-Infective Ophthalmic Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infective Ophthalmic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infective Ophthalmic Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infective Ophthalmic Breakdown Data by Company
3.1.1 Global Anti-Infective Ophthalmic Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infective Ophthalmic Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infective Ophthalmic Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infective Ophthalmic Revenue by Company (2020-2025)
3.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infective Ophthalmic Sale Price by Company
3.4 Key Manufacturers Anti-Infective Ophthalmic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infective Ophthalmic Product Location Distribution
3.4.2 Players Anti-Infective Ophthalmic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVE OPHTHALMIC BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infective Ophthalmic Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infective Ophthalmic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infective Ophthalmic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infective Ophthalmic Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infective Ophthalmic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infective Ophthalmic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infective Ophthalmic Sales Growth
4.4 APAC Anti-Infective Ophthalmic Sales Growth
4.5 Europe Anti-Infective Ophthalmic Sales Growth
4.6 Middle East & Africa Anti-Infective Ophthalmic Sales Growth
5 AMERICAS
5.1 Americas Anti-Infective Ophthalmic Sales by Country
5.1.1 Americas Anti-Infective Ophthalmic Sales by Country (2020-2025)
5.1.2 Americas Anti-Infective Ophthalmic Revenue by Country (2020-2025)
5.2 Americas Anti-Infective Ophthalmic Sales by Type (2020-2025)
5.3 Americas Anti-Infective Ophthalmic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infective Ophthalmic Sales by Region
6.1.1 APAC Anti-Infective Ophthalmic Sales by Region (2020-2025)
6.1.2 APAC Anti-Infective Ophthalmic Revenue by Region (2020-2025)
6.2 APAC Anti-Infective Ophthalmic Sales by Type (2020-2025)
6.3 APAC Anti-Infective Ophthalmic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infective Ophthalmic by Country
7.1.1 Europe Anti-Infective Ophthalmic Sales by Country (2020-2025)
7.1.2 Europe Anti-Infective Ophthalmic Revenue by Country (2020-2025)
7.2 Europe Anti-Infective Ophthalmic Sales by Type (2020-2025)
7.3 Europe Anti-Infective Ophthalmic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infective Ophthalmic by Country
8.1.1 Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infective Ophthalmic Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infective Ophthalmic Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infective Ophthalmic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infective Ophthalmic
10.3 Manufacturing Process Analysis of Anti-Infective Ophthalmic
10.4 Industry Chain Structure of Anti-Infective Ophthalmic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infective Ophthalmic Distributors
11.3 Anti-Infective Ophthalmic Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVE OPHTHALMIC BY GEOGRAPHIC REGION
12.1 Global Anti-Infective Ophthalmic Market Size Forecast by Region
12.1.1 Global Anti-Infective Ophthalmic Forecast by Region (2026-2031)
12.1.2 Global Anti-Infective Ophthalmic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infective Ophthalmic Forecast by Type (2026-2031)
12.7 Global Anti-Infective Ophthalmic Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alcon
13.1.1 Alcon Company Information
13.1.2 Alcon Anti-Infective Ophthalmic Product Portfolios and Specifications
13.1.3 Alcon Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alcon Main Business Overview
13.1.5 Alcon Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Anti-Infective Ophthalmic Product Portfolios and Specifications
13.2.3 AbbVie Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Bausch Health
13.3.1 Bausch Health Company Information
13.3.2 Bausch Health Anti-Infective Ophthalmic Product Portfolios and Specifications
13.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bausch Health Main Business Overview
13.3.5 Bausch Health Latest Developments
13.4 Santen Pharmaceutical
13.4.1 Santen Pharmaceutical Company Information
13.4.2 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolios and Specifications
13.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Santen Pharmaceutical Main Business Overview
13.4.5 Santen Pharmaceutical Latest Developments
13.5 Lupin Pharmaceuticals
13.5.1 Lupin Pharmaceuticals Company Information
13.5.2 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
13.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lupin Pharmaceuticals Main Business Overview
13.5.5 Lupin Pharmaceuticals Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Anti-Infective Ophthalmic Product Portfolios and Specifications
13.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Akorn
13.7.1 Akorn Company Information
13.7.2 Akorn Anti-Infective Ophthalmic Product Portfolios and Specifications
13.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Akorn Main Business Overview
13.7.5 Akorn Latest Developments
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Information
13.8.2 Johnson & Johnson Anti-Infective Ophthalmic Product Portfolios and Specifications
13.8.3 Johnson & Johnson Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Johnson & Johnson Main Business Overview
13.8.5 Johnson & Johnson Latest Developments
13.9 Thea pharmaceuticals
13.9.1 Thea pharmaceuticals Company Information
13.9.2 Thea pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
13.9.3 Thea pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Thea pharmaceuticals Main Business Overview
13.9.5 Thea pharmaceuticals Latest Developments
13.10 URSAPHARM
13.10.1 URSAPHARM Company Information
13.10.2 URSAPHARM Anti-Infective Ophthalmic Product Portfolios and Specifications
13.10.3 URSAPHARM Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 URSAPHARM Main Business Overview
13.10.5 URSAPHARM Latest Developments
13.11 SIMILASAN
13.11.1 SIMILASAN Company Information
13.11.2 SIMILASAN Anti-Infective Ophthalmic Product Portfolios and Specifications
13.11.3 SIMILASAN Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SIMILASAN Main Business Overview
13.11.5 SIMILASAN Latest Developments
13.12 Jianfeng Group
13.12.1 Jianfeng Group Company Information
13.12.2 Jianfeng Group Anti-Infective Ophthalmic Product Portfolios and Specifications
13.12.3 Jianfeng Group Anti-Infective Ophthalmic Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jianfeng Group Main Business Overview
13.12.5 Jianfeng Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-Infective Ophthalmic Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infective Ophthalmic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Eyedrops
Table 4. Major Players of Gels
Table 5. Major Players of Ointments
Table 6. Major Players of Other
Table 7. Global Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 8. Global Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Table 9. Global Anti-Infective Ophthalmic Revenue byType (2020-2025) & ($ million)
Table 10. Global Anti-Infective Ophthalmic Revenue Market Share byType (2020-2025)
Table 11. Global Anti-Infective Ophthalmic Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Anti-Infective Ophthalmic Sale by Application (2020-2025) & (K Units)
Table 13. Global Anti-Infective Ophthalmic Sale Market Share by Application (2020-2025)
Table 14. Global Anti-Infective Ophthalmic Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-Infective Ophthalmic Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-Infective Ophthalmic Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Anti-Infective Ophthalmic Sales by Company (2020-2025) & (K Units)
Table 18. Global Anti-Infective Ophthalmic Sales Market Share by Company (2020-2025)
Table 19. Global Anti-Infective Ophthalmic Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-Infective Ophthalmic Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-Infective Ophthalmic Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Anti-Infective Ophthalmic Producing Area Distribution and Sales Area
Table 23. Players Anti-Infective Ophthalmic Products Offered
Table 24. Anti-Infective Ophthalmic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-Infective Ophthalmic Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Anti-Infective Ophthalmic Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-Infective Ophthalmic Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-Infective Ophthalmic Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-Infective Ophthalmic Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Anti-Infective Ophthalmic Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-Infective Ophthalmic Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-Infective Ophthalmic Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 36. Americas Anti-Infective Ophthalmic Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-Infective Ophthalmic Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 39. Americas Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 40. APAC Anti-Infective Ophthalmic Sales by Region (2020-2025) & (K Units)
Table 41. APAC Anti-Infective Ophthalmic Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-Infective Ophthalmic Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 44. APAC Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 45. Europe Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 46. Europe Anti-Infective Ophthalmic Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 48. Europe Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-Infective Ophthalmic Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Anti-Infective Ophthalmic Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-Infective Ophthalmic
Table 54. Key Market Challenges & Risks of Anti-Infective Ophthalmic
Table 55. Key IndustryTrends of Anti-Infective Ophthalmic
Table 56. Anti-Infective Ophthalmic Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-Infective Ophthalmic Distributors List
Table 59. Anti-Infective Ophthalmic Customer List
Table 60. Global Anti-Infective Ophthalmic SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Anti-Infective Ophthalmic RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Anti-Infective Ophthalmic Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-Infective Ophthalmic SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Anti-Infective Ophthalmic Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Anti-Infective Ophthalmic RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-Infective Ophthalmic SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Anti-Infective Ophthalmic RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-Infective Ophthalmic SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Anti-Infective Ophthalmic RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Anti-Infective Ophthalmic SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Anti-Infective Ophthalmic RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Alcon Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 75. Alcon Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 76. Alcon Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Alcon Main Business
Table 78. Alcon Latest Developments
Table 79. AbbVie Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 81. AbbVie Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. Bausch Health Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 85. Bausch Health Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 86. Bausch Health Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bausch Health Main Business
Table 88. Bausch Health Latest Developments
Table 89. Santen Pharmaceutical Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 90. Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 91. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Santen Pharmaceutical Main Business
Table 93. Santen Pharmaceutical Latest Developments
Table 94. Lupin Pharmaceuticals Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 96. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Lupin Pharmaceuticals Main Business
Table 98. Lupin Pharmaceuticals Latest Developments
Table 99. Apotex Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 100. Apotex Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 101. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Apotex Main Business
Table 103. Apotex Latest Developments
Table 104. Akorn Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 105. Akorn Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 106. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Akorn Main Business
Table 108. Akorn Latest Developments
Table 109. Johnson & Johnson Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 111. Johnson & Johnson Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Johnson & Johnson Main Business
Table 113. Johnson & Johnson Latest Developments
Table 114.Thea pharmaceuticals Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 115.Thea pharmaceuticals Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 116.Thea pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117.Thea pharmaceuticals Main Business
Table 118.Thea pharmaceuticals Latest Developments
Table 119. URSAPHARM Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 120. URSAPHARM Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 121. URSAPHARM Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. URSAPHARM Main Business
Table 123. URSAPHARM Latest Developments
Table 124. SIMILASAN Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 125. SIMILASAN Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 126. SIMILASAN Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. SIMILASAN Main Business
Table 128. SIMILASAN Latest Developments
Table 129. Jianfeng Group Basic Information, Anti-Infective Ophthalmic Manufacturing Base, Sales Area and Its Competitors
Table 130. Jianfeng Group Anti-Infective Ophthalmic Product Portfolios and Specifications
Table 131. Jianfeng Group Anti-Infective Ophthalmic Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Jianfeng Group Main Business
Table 133. Jianfeng Group Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-Infective Ophthalmic
Figure 2. Anti-Infective Ophthalmic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infective Ophthalmic Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infective Ophthalmic Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infective Ophthalmic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infective Ophthalmic Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infective Ophthalmic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Eyedrops
Figure 12. Product Picture of Gels
Figure 13. Product Picture of Ointments
Figure 14. Product Picture of Other
Figure 15. Global Anti-Infective Ophthalmic Sales Market Share byType in 2025
Figure 16. Global Anti-Infective Ophthalmic Revenue Market Share byType (2020-2025)
Figure 17. Anti-Infective Ophthalmic Consumed in Hospital
Figure 18. Global Anti-Infective Ophthalmic Market: Hospital (2020-2025) & (K Units)
Figure 19. Anti-Infective Ophthalmic Consumed in Retail Pharmacy
Figure 20. Global Anti-Infective Ophthalmic Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Anti-Infective Ophthalmic Consumed in Others
Figure 22. Global Anti-Infective Ophthalmic Market: Others (2020-2025) & (K Units)
Figure 23. Global Anti-Infective Ophthalmic Sale Market Share by Application (2024)
Figure 24. Global Anti-Infective Ophthalmic Revenue Market Share by Application in 2025
Figure 25. Anti-Infective Ophthalmic Sales by Company in 2025 (K Units)
Figure 26. Global Anti-Infective Ophthalmic Sales Market Share by Company in 2025
Figure 27. Anti-Infective Ophthalmic Revenue by Company in 2025 ($ millions)
Figure 28. Global Anti-Infective Ophthalmic Revenue Market Share by Company in 2025
Figure 29. Global Anti-Infective Ophthalmic Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Anti-Infective Ophthalmic Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 32. Americas Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 33. APAC Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 34. APAC Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 35. Europe Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 36. Europe Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Anti-Infective Ophthalmic Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Anti-Infective Ophthalmic Revenue 2020-2025 ($ millions)
Figure 39. Americas Anti-Infective Ophthalmic Sales Market Share by Country in 2025
Figure 40. Americas Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Figure 41. Americas Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 42. Americas Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 43. United States Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Anti-Infective Ophthalmic Sales Market Share by Region in 2025
Figure 48. APAC Anti-Infective Ophthalmic Revenue Market Share by Region (2020-2025)
Figure 49. APAC Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 50. APAC Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 51. China Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 55. India Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Anti-Infective Ophthalmic Sales Market Share by Country in 2025
Figure 59. Europe Anti-Infective Ophthalmic Revenue Market Share by Country (2020-2025)
Figure 60. Europe Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 61. Europe Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 62. Germany Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 63.France Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share by Application (2020-2025)
Figure 70. Egypt Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Anti-Infective Ophthalmic Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Anti-Infective Ophthalmic in 2025
Figure 76. Manufacturing Process Analysis of Anti-Infective Ophthalmic
Figure 77. Industry Chain Structure of Anti-Infective Ophthalmic
Figure 78. Channels of Distribution
Figure 79. Global Anti-Infective Ophthalmic Sales MarketForecast by Region (2026-2031)
Figure 80. Global Anti-Infective Ophthalmic Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Anti-Infective Ophthalmic Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Anti-Infective Ophthalmic Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Anti-Infective Ophthalmic Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Anti-Infective Ophthalmic Revenue Market ShareForecast by Application (2026-2031)
